Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
  2. Gatti-Mays, Margaret E.; Strauss, Julius; Donahue, Renee N.; Palena, Claudia; Del Rivero, Jaydira; Redman, Jason M.; Madan, Ravi A.; Marte, Jennifer L.; Cordes, Lisa M.; Lamping, Elizabeth; Orpia,Alanvin; Burmeister, Andrea; Wagner, Eva; Navarro, Cesar Pico; Heery, Christopher R.; Schlom, Jeffrey; Gulley, James L.
  3. CLINICAL CANCER RESEARCH. 2019, Aug 15; 25(16): 4933-4944.
  1. 2.   Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route
  2. Johnson, R. F.; Dyall, J.; Ragl, D. R.; Huzella, L.; Byrum, R.; Jett, C.; St Claire, M.; Smith, A. L.; Paragas, J.; Blaney, J. E.; Jahrling, P. B.
  3. Journal of Virology. 2011, Mar; 85(5): 2112-2125.
  1. 3.   Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin
  2. Fisher, R. W.; Reed, J. L.; Snoy, P. J.; Mikolajczyk, M. G.; Bray, M.; Scott, D. E.; Kennedy, M. C.
  3. Clinical and Vaccine Immunology. 2011, Jan; 18(1): 67-74.
  1. 4.   Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys
  2. Zielinski, R. J.; Smedley, J. V.; Perera, P. Y.; Silvera, P. M.; Waldmann, T. A.; Capala, J.; Perera, L. P.
  3. Vaccine. 2010, Oct; 28(43): 7081-7091.
  1. 5.   DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  2. Nigam, P.; Earl, P. L.; Americo, J. L.; Sharma, S.; Wyatt, L. S.; Edghill-Spano, Y.; Chennareddi, L. S.; Silvera, P.; Moss, B.; Robinson, H. L.; Amara, R. R.
  3. Virology. 2007, Sep; 366(1): 73-83.
  1. 6.   Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  2. Earl, P. L.; Americo, J. L.; Wyatt, L. S.; Eller, L. A.; Montefiori, D. C.; Byrum, R.; Piatak, M.; Lifson, J. D.; Amara, R. R.; Robinson, H. L.; Huggins, J. W.; Moss, B.
  3. Virology. 2007, Sep; 366(1): 84-97.
  1. 7.   Subunit recombinant vaccine protects against monkeypox
  2. Heraud, J. M.; Edghill-Smith, Y.; Ayala, V.; Kalisz, I.; Parrino, J.; Kalyanaraman, V. S.; Manischewitz, J.; King, L. R.; Hryniewicz, A.; Trindade, C. J.; Hassett, M.; Tsai, W. P.; Venzon, D.; Nalca, A.; Vaccari, M.; Silvera, P.; Bray, M.; Graham, B. S.; Golding, H.; Hooper, J. W.; Franchini, G.
  3. Journal of Immunology. 2006, Aug; 177(4): 2552-2564.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel